Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic total occlusions in Sweden--a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Råmunddal T, Hoebers LP, Henriques JP, Dworeck C, Angerås O, Odenstedt J, Ioanes D, Olivecrona G, Harnek J, Jensen U, Aasa M, Jussila R, James S, Lagerqvist B, Matejka G, Albertsson P, Omerovic E. Råmunddal T, et al. Among authors: james s. PLoS One. 2014 Aug 12;9(8):e103850. doi: 10.1371/journal.pone.0103850. eCollection 2014. PLoS One. 2014. PMID: 25117457 Free PMC article.
Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Koutouzis M, Lagerqvist B, James S, Omerovic E, Matejka G, Grip L, Albertsson P. Koutouzis M, et al. Among authors: james s. Heart. 2011 Sep;97(18):1484-8. doi: 10.1136/hrt.2011.224709. Epub 2011 Apr 12. Heart. 2011. PMID: 21487123
Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Sarno G, Lagerqvist B, Fröbert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S. Sarno G, et al. Among authors: james s. Eur Heart J. 2012 Mar;33(5):606-13. doi: 10.1093/eurheartj/ehr479. Epub 2012 Jan 9. Eur Heart J. 2012. PMID: 22232428
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Sarno G, Lagerqvist B, Carlsson J, Olivecrona G, Nilsson J, Calais F, Götberg M, Nilsson T, Sjögren I, James S. Sarno G, et al. Among authors: james s. Int J Cardiol. 2013 Jul 15;167(1):146-50. doi: 10.1016/j.ijcard.2011.12.057. Epub 2012 Jan 13. Int J Cardiol. 2013. PMID: 22244480
Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.
Kedhi E, Gomes ME, Lagerqvist B, Smith JG, Omerovic E, James S, Harnek J, Olivecrona GK. Kedhi E, et al. Among authors: james s. JACC Cardiovasc Interv. 2012 Nov;5(11):1141-9. doi: 10.1016/j.jcin.2012.06.020. JACC Cardiovasc Interv. 2012. PMID: 23174638 Free article.
3,511 results